161 related articles for article (PubMed ID: 11120951)
1. Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.
Baltch AL; Smith RP; Franke MA; Ritz WJ; Michelsen PB; Bopp LH
Antimicrob Agents Chemother; 2001 Jan; 45(1):96-104. PubMed ID: 11120951
[TBL] [Abstract][Full Text] [Related]
2. The effects of fluconazole and cytokines on human mononuclear cells.
Fidan I; Yuksel S; Imir T; Kalkanci A; Kustimur S; Ilhan MN
Mem Inst Oswaldo Cruz; 2007 May; 102(2):127-31. PubMed ID: 17426874
[TBL] [Abstract][Full Text] [Related]
3. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
Baltch AL; Bopp LH; Smith RP; Ritz WJ; Carlyn CJ; Michelsen PB
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):299-304. PubMed ID: 15893901
[TBL] [Abstract][Full Text] [Related]
4. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.
Natarajan U; Randhawa N; Brummer E; Stevens DA
J Med Microbiol; 1998 Apr; 47(4):359-63. PubMed ID: 9569003
[TBL] [Abstract][Full Text] [Related]
5. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Vora S; Purimetla N; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1998 Apr; 42(4):907-10. PubMed ID: 9559806
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients.
Tascini C; Vecchiarelli A; Preziosi R; Francisci D; Bistoni F; Baldelli F
AIDS; 1999 Jan; 13(1):49-55. PubMed ID: 10207544
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.
Wang M; Friedman H; Djeu JY
J Immunol; 1989 Jul; 143(2):671-7. PubMed ID: 2661688
[TBL] [Abstract][Full Text] [Related]
8. Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes.
Baltch AL; Bopp LH; Smith RP; Ritz WJ; Michelsen PB
J Antimicrob Chemother; 2008 Dec; 62(6):1285-90. PubMed ID: 18772160
[TBL] [Abstract][Full Text] [Related]
9. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma enhances killing of methicillin-resistant Staphylococcus aureus by human monocytes more effectively than GM-CSF in the presence of daptomycin and other antibiotics.
Smith RP; Baltch AL; Ritz WJ; Michelsen PB; Bopp LH
Cytokine; 2010 Sep; 51(3):274-7. PubMed ID: 20580568
[TBL] [Abstract][Full Text] [Related]
11. Effect of iron on fluconazole activity against Candida albicans in presence of human serum or monocyte-derived macrophages.
Minn Y; Brummer E; Stevens DA
Mycopathologia; 1997; 138(1):29-35. PubMed ID: 9404022
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal activity of the berberine and its synergism with fluconazole.
Iwazaki RS; Endo EH; Ueda-Nakamura T; Nakamura CV; Garcia LB; Filho BP
Antonie Van Leeuwenhoek; 2010 Feb; 97(2):201-5. PubMed ID: 19882381
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm.
Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N
Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371
[TBL] [Abstract][Full Text] [Related]
15. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
Hirasawa M; Takada K
J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042
[TBL] [Abstract][Full Text] [Related]
16. Prevention and reversal of tumor cell-induced monocyte deactivation by cytokines, purified protein derivative (PPD), and anti-IL-10 antibody.
Baj-Krzyworzeka M; Baran J; Szatanek R; Stankiewicz D; Siedlar M; Zembala M
Cancer Immun; 2004 Aug; 4():8. PubMed ID: 15327279
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms.
Yu Q; Ding X; Xu N; Cheng X; Qian K; Zhang B; Xing L; Li M
Int J Antimicrob Agents; 2013 Feb; 41(2):179-82. PubMed ID: 23265915
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
19. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.
Shi W; Chen Z; Chen X; Cao L; Liu P; Sun S
FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans.
Han B; Chen J; Yu YQ; Cao YB; Jiang YY
Microbiol Immunol; 2016 Feb; 60(2):82-92. PubMed ID: 26891940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
